AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 45 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $271,000 | -17.9% | 402,118 | 0.0% | 0.07% | -18.9% |
| Q1 2019 | $330,000 | -48.7% | 402,118 | 0.0% | 0.09% | -49.2% |
| Q4 2018 | $643,000 | -51.7% | 402,118 | 0.0% | 0.18% | -26.9% |
| Q3 2018 | $1,331,000 | +46.4% | 402,118 | 0.0% | 0.24% | +10.5% |
| Q2 2018 | $909,000 | -67.5% | 402,118 | -58.3% | 0.22% | -85.5% |
| Q1 2018 | $2,797,000 | +3.9% | 964,520 | 0.0% | 1.51% | +19.9% |
| Q4 2017 | $2,691,000 | -68.5% | 964,520 | -58.8% | 1.26% | -68.2% |
| Q3 2017 | $8,543,000 | +24.5% | 2,340,673 | -24.3% | 3.96% | -17.7% |
| Q2 2017 | $6,861,000 | +184.3% | 3,090,673 | -24.4% | 4.82% | +289.9% |
| Q1 2017 | $2,413,000 | +72.5% | 4,090,673 | +57.9% | 1.24% | +23.4% |
| Q4 2016 | $1,399,000 | -39.3% | 2,590,673 | 0.0% | 1.00% | -39.6% |
| Q3 2016 | $2,306,000 | -7.4% | 2,590,673 | 0.0% | 1.66% | -22.5% |
| Q2 2016 | $2,490,000 | – | 2,590,673 | – | 2.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 20,896,038 | $17,135,000 | 0.89% |
| X-Square Capital, LLC | 270,680 | $222,000 | 0.15% |
| New Leaf Venture Partners, L.L.C. | 402,118 | $330,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 688,431 | $565,000 | 0.06% |
| EXCALIBUR MANAGEMENT CORP | 51,000 | $42,000 | 0.04% |
| WealthTrust Axiom LLC | 138,505 | $113,000 | 0.04% |
| Caption Management, LLC | 855,200 | $701,000 | 0.04% |
| Evercore Wealth Management, LLC | 418,414 | $343,000 | 0.01% |
| Gemmer Asset Management LLC | 1,939 | $32,000 | 0.01% |
| Ausdal Financial Partners, Inc. | 23,000 | $19,000 | 0.01% |